Advanced in Defective Apolipoprotein B-100

Jean-pierre H. Rabes

Montigny-sur-loing, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Defective Apolipoprotein B-100
Montigny-sur-loing, FR 
OverviewLocationsClinical Research

Overview

Jean-pierre Rabes practices in Montigny-sur-loing, France. Mr. Rabes is rated as an Advanced expert by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Familial Hypercholesterolemia, Defective Apolipoprotein B-100, High Cholesterol, and Heterozygous Familial Hypercholesterolemia (HeFH).

His clinical research consists of co-authoring 33 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 16 articles in the study of Defective Apolipoprotein B-100.

Gender
Male

Locations

Montigny-sur-loing, France
Other Locations
Paris, 75018, France
Boulogne-billancourt, France
Saint-quentin-le-verger, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Enrollment Status: Recruiting
Publish Date: February 11, 2025
Intervention Type: Other

33 Total Publications

Comparison of two genetic strategies for diagnostic work-up of hypertrophic cardiomyopathy: impact on the diagnosis of Fabry disease or transthyretin amyloidosis.
Comparison of two genetic strategies for diagnostic work-up of hypertrophic cardiomyopathy: impact on the diagnosis of Fabry disease or transthyretin amyloidosis.
Journal: Orphanet journal of rare diseases
Published: June 10, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rabes's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile